Price regulation of essential drugs: Cost of insulin Glargine reduced

1 min read
Read later

Representative Image | Photo: AFP

Thrissur: The price of insulin Glargine used to treat type 1 diabetes will considerably decrease as part of the central government’s measures to curtail the hike in Wholesale Price Index (WPI) of essential medicines.

The new ceiling price of insulin Glargine (injection) is now Rs 217.74 down from Rs 244.13 and cartridges and vials of the drug will be available for Rs 181.45 (excluding GST).

Insulin Glargine has been added to the list of essential drugs recently despite the manufactures’ objections to its inclusion or regulation of its price due to the use if novel technology in its production.

The National Pharmaceutical Pricing Authority observed that the drug cannot be excluded from the list if essential medicines by based solely merely on differences in administration.

Add Comment
Related Topics

Get daily updates from

Disclaimer: Kindly avoid objectionable, derogatory, unlawful and lewd comments, while responding to reports. Such comments are punishable under cyber laws. Please keep away from personal attacks. The opinions expressed here are the personal opinions of readers and not that of Mathrubhumi.


4 min

Lifestyle changes increase risk of heart disease in women

Sep 29, 2023


2 min

Vaccination drive to be expanded, expert panel hands over recommendations to Kerala govt 

Nov 20, 2022

say no to drugs

4 min

International Day Against Drug Abuse | Stop Stigma and Discrimination, Strengthen Prevention

Jun 26, 2023